Female Viagra or FSD medication has finally arrived. Recently an FDA review panel voted to approve the first oral medication for female sexual dysfunction (FSD). The panel voted 18-6 to recommend approval of flibanserin, the so-called “female Viagra.”
Flibanserin, is supposed to increase libido, or improve low sexual desire.
The vote does not mean that the drug will automatically be approved for production, but the FDA usually follows the recommendations of its review committees. The FDA is expected to make a final decision on approval before the end of the summer.
This is not flibanserin’s first trip to the rodeo. The FDA has already failed to approve it twice, based on a significant number of reported undesirable side-effects including: headaches, nausea, fainting spells, and lowering of blood pressure.
Even the recent panel, while recommending approval, stated that the drugs benefits, only “marginally” outweighed its potential side effects.
Female Viagra – FSD Medication
FSD is more of a range of sexual wellness issues, from decreased libido to painful intercourse. This is the opposite of erectile dysfunction, which is a specific condition that can be treated.
Flibanserin, the so called female Viagra, is indicated to treat only one aspect of FSD, low-libido, or what the developers of the drug refer to as, Hypoactive Sexual Desire Disorder.
Even if approved, this female Viagra will only benefit a specific portion of the female population having sexual wellness issues. The drug only increases “desire,” in women that seem to have lost interest in sex.
This new female viagra cannot help with other “performance” issues. For example, it won’t help with painful intercourse, lack of sensitivity, or decreased lubrication, which are the very complaints that many women present with, particularly as they get older.
Sprout Pharmaceuticals, the creators of the “female Viagra”, showed the panel a series of double-blind clinical trials. These trials that indicted the drug worked better than a placebo in increasing sexual desire in otherwise healthy women.
Women with decreased libido earnestly testified before the panel, saying they wanted help, and their doctors could offer them none.
Female Viagra Alternatives
There is certainly quite the media buzz about the “Female Viagra.” whether it gains the popularity of, or proves to be as effective as, its blue male counterpart, remains to be seen.
In the meantime, we have some very effective, all natural drug-free and side-effect free treatments available for women suffering with decreased libido, or other sexual wellness issues.
The O-shot, a vaginal rejuvenation procedure, uses your own blood to enhance your sexual experience. The secret to the O-shot is platelet rich plasma, or PRP. PRP is a solution created from a small sample of blood, which through a centrifugal process, is concentrated with healing and growth factors.
When used for women in the painless O-shot, it increases sensitivity, and increases the ability to obtain an orgasm. Additionally, increased lubrication is another immediate results.
With sexual satisfaction improved from the revitalizing effect of the O-shot, women also report improved libido, or an increase in sexual desire.
For some women experiencing sexual wellness issues, in addition to the O-shot, hormone optimization may be indicated. Hormone replacement therapy using all-natural, bioidentical hormones, has also been shown to improve arousal and increase libido in women.
While I empathize with the women who testified before the committee about their problems with lack of desire. They have been misled by a conventional medical establishment that is in the pockets of big Pharma, to believe that without the approval of this drug, they have no help available.
That is simply untrue. Rather than wait for the approval of this female viagra, who by the panel’s own admission has only “marginal” benefits at best, I urge any woman suffering from decreased libido to contact my office.
Have you or anyone you know tried any sexual wellness treatments? What were the results?
Start the conversation below.
